U.S., Jan. 28 -- ClinicalTrials.gov registry received information related to the study (NCT06794567) titled 'Genomic First Testing in Chronic Kidney Disease' on Jan. 08.
Brief Summary: This multi-center study examines the role of genetic testing in patients with chronic kidney disease (CKD) who are identified as being at risk for genetic kidney disease, based on Ontario Health's Provincial Genetic Program (OH-PGP) guidelines. Participants will be assigned to either genome-wide sequencing or standard genetic testing, depending on when they were initially diagnosed with kidney disease.
To evaluate the impact of genetic testing, patients and caregivers will complete quality-of-life questionnaires before and after testing. Participants may al...